Form 4 for LYEL Lyell Immunopharma, Inc.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0001415889-25-009604 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | 2025-03-31 | LYEL | BRAWLEY OTIS W | Dir | P - Purchase | $0.56 | +35.6K | 35.6K | New | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | P | A | 35,640 | $0.56 | 35,640 | D | — | — |